Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

F Simko, RJ Reiter - Life sciences, 2020 - ncbi.nlm.nih.gov
An article by Zhang et al.[1] published in the March issue of Life Sciences suggested
melatonin as a potential adjuvant treatment for COVID-19. Besides the antioxidative and …
被引用次数：16 相关文章

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

F Simko, RJ Reiter - Life Sciences, 2020 - europepmc.org
An article by Zhang et al.[1] published in the March issue of Life Sciences suggested
melatonin as a potential adjuvant treatment for COVID-19. Besides the antioxidative and …

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

F Simko, RJ Reiter - Life sciences, 2020 - pubmed.ncbi.nlm.nih.gov
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Is
melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Life Sci …

[引用][C] Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

F Simko, RJ Reiter - Life Sciences, 2020 - scholars.uthscsa.edu
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? —
Scholars @ UT Health San Antonio Skip to main navigation Skip to search Skip to main content …

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?

F Simko, RJ Reiter - 2020 - expeditiorepositorio.utadeo.edu.co
An article by Zhang et al.[1] published in the March issue of Life Sciences suggested
melatonin as a potential adjuvant treatment for COVID-19. Besides the antioxidative and …